Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia (Interfant06)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2014 by Dutch Childhood Oncology Group.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
BFM Germany
CORS Monza Italy
Associazione Italiana Ematologia Oncologia Pediatrica
Australian and New Zealand Children's Oncology Group
BFM Austria
CLCG France Belgium Portugal
COALL Germany
CPH, Czech republic
DFCI consortium USA
FRALLE France
Hong Kong
MD Anderson USA
NOPHO Scandinavian countries
PINDA, Chile
PPLLSG Poland
Seattle USA
SJCRH USA
UKCCSG United Kingdom
Information provided by (Responsible Party):
Dutch Childhood Oncology Group
ClinicalTrials.gov Identifier:
NCT00550992
First received: October 22, 2007
Last updated: February 14, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)